Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer
Guopeng Yu, Jia-hao Bao, Ming Zhan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 194
m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization
Ning Wang, Rixin Chen, Minhua Deng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 50
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization
Shaomin Zou, Yizhi Huang, Ziqing Yang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 17
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape
Yuxin Kong, Jie Yu, Shengfang Ge, et al.
The Innovation (2023) Vol. 4, Iss. 4, pp. 100452-100452
Open Access | Times Cited: 24
Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential
Ngoc Thi Minh Dinh, Tuan Minh Nguyen, Mi Kyung Park, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 717-717
Open Access | Times Cited: 12
NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization
Zhen Zhao, Yujie Zhou, Peng Lv, et al.
Cancer Letters (2024) Vol. 597, pp. 217059-217059
Open Access | Times Cited: 9
Detection, molecular function and mechanisms of m5C in cancer
Linhui Zhang, Yuelong Li, Liqing Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Vital roles of m5C RNA modification in cancer and immune cell biology
Xinyu Gu, Xiao Ma, Chao Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency
Rui Xu, Yue Wang, Ye Kuang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon
Yiqi Sun, Yunfei Liu, Lu Jiang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
5-Methylcytosine methylation predicts cervical cancer prognosis, shaping immune cell infiltration
Luyang Su, Ren Xu, Yanan Ren, et al.
Journal of International Medical Research (2025) Vol. 53, Iss. 4
Open Access
An electrochemical biosensor for detecting DNA methylation based on AuNPs/rGO/g-C3N4 nanocomposite
Junming Bao, Kejian Ding, Yunfeng Zhu
Analytical Biochemistry (2023) Vol. 673, pp. 115180-115180
Closed Access | Times Cited: 12
Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer
Mingxing Zhang, Yani Su, Pengfei Wen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
NSUN2/ALYREF axis-driven m5C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer
Yiran Yang, Leiqun Cao, Xin Xu, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation
Jinhua Jiang, Feng Liu, Dan Cui, et al.
Cancer Communications (2025)
Open Access
Direct RNA sequencing reveals chicken post-transcriptional modifications in response to Campylobacter jejuni inoculation
Yanan Zhao, Yuanmei Wang, Yanru Ren, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer
Zhansheng Lu, Bo Liu, Demiao Kong, et al.
Medical Principles and Practice (2023) Vol. 33, Iss. 1, pp. 56-65
Open Access | Times Cited: 9
Machine Learning-based Development and Validation of a Cell Senescence Predictive and Prognostic Signature in Intrahepatic Cholangiocarcinoma
Ruida Yang, Feidi Sun, Yu Shi, et al.
Journal of Cancer (2024) Vol. 15, Iss. 9, pp. 2810-2828
Open Access | Times Cited: 3
Study of the Immune Infiltration and Sonic Hedgehog Expression Mechanism in Synovial Tissue of Rheumatoid Arthritis-Related Interstitial Lung Disease under Machine Learning CIBERSORT Algorithm
Qunqun Lu, Yizhen Jiang, Xiaofeng Cang, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.
Lemei Zheng, Yumei Duan, Mengna Li, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 6125-6146
Closed Access | Times Cited: 7
The role of m5C RNA modification in cancer development and therapy
Li Yu, Hongen Xu, Hanchu Xiong, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38660-e38660
Open Access | Times Cited: 2
Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
Shouyi Zhang, Tao Shen, Yu Zeng
Cancers (2023) Vol. 15, Iss. 8, pp. 2243-2243
Open Access | Times Cited: 6
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy
Hongtuan Zhang, Dongze Liu, Qin Zheng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top